Materials Engineering

Story Title Content type Authored by Authored on
School of Materials Science & Engineering | 2022 Brumley D. Pritchett Lecture Event Christa Ernst
5 Questions with the New IMat Advisory Team | Functional Organic Materials News Christa Ernst
Materials Informatics 101 Virtual Course Event Christa Ernst
5 Questions with the IMat Advisory Team | Featuring Matt McDowell News Christa Ernst
Direct Fabrication and Tailoring of Soft Robot Bodies Event Christa Ernst
GTRI Scientist Leads Multi-Organization Material Science Mission to International Space Station News Christa Ernst
SENIC Ambassadors Webinar Series: Toolbox for Nucleation and Crystal Growth at Single Entity Resolutions by Controlling Nanoscale Transport Event Christa Ernst
SENIC Ambassadors Webinar Series: Heat Transfer Across Length Scales – Focus on Thermal Management and Advanced Sensing Event Christa Ernst
Nano@Tech Virtual:Engineering Human Stem Cells for Treating Cardiac Diseases Event Christa Ernst
Spring 2020 NANOFANS Webinar Series - “Nanotechnology in Infectious Diseases (Diagnostics/Therapeutics)”: Session 5 -“Virus-Like Particle Approaches to Coronavirus Diagnostics and Vaccines” Event jhunt7
Surfaces That Grip Like Gecko Feet Could Be Easily Mass-Produced News Ben Brumfield
Spring 2020 NANOFANS Webinar Series - “Nanotechnology in Infectious Diseases (Diagnostics/Therapeutics)”: Session 5 -“Virus-Like Particle Approaches to Coronavirus Diagnostics and Vaccines” Event kkarunakaran3
Spring 2020 NANOFANS Webinar Series - “Nanotechnology in Infectious Diseases (Diagnostics/Therapeutics)”: Session 4 - “Engineered Biomaterials Reveal Viral Immunity Mechanisms and Augment Therapy” Event kkarunakaran3
Spring 2020 NANOFANS Webinar Series - “Nanotechnology in Infectious Diseases (Diagnostics/Therapeutics)”: Session 3 - “Point-of-Care Diagnostics via DNA-Based Isothermal Amplification and Paper Test” Event kkarunakaran3
Spring 2020 NANOFANS Webinar Series - “Nanotechnology in Infectious Diseases (Diagnostics/Therapeutics)”: Session 2 - “RNA-based Drugs for Treating Influenza and SARS-CoV-2” Event kkarunakaran3